Singapore markets close in 2 hours 10 minutes

Viatris Inc. (VTRS)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
11.76-0.18 (-1.51%)
At close: 04:00PM EDT
11.71 -0.05 (-0.43%)
After hours: 07:58PM EDT
Full screen
Loading interactive chart…
  • Reuters

    UPDATE 2-US FDA declines to approve Viatris's injection for multiple sclerosis

    The U.S. FDA has declined to approve Viatris and Mapi Pharma's once-a-month injection for treating relapsing forms of debilitating neurological condition multiple sclerosis (MS), the companies said on Monday. The companies were reviewing the content of the health regulator's so called complete response letter (CRL) and would soon determine the appropriate next steps, they said, without disclosing further details. Mapi Pharma did not immediately respond to Reuters requests for additional details on the contents of the CRL, which indicates that an application would not be approved in its present form and requires more information.

  • GuruFocus.com

    Viatris Inc's Dividend Analysis

    Viatris Inc (NASDAQ:VTRS) recently announced a dividend of $0.12 per share, payable on 2024-03-18, with the ex-dividend date set for 2024-03-08. As investors look forward to this upcoming payment, the spotlight also shines on the company's dividend history, yield, and growth rates. Using the data from GuruFocus, let's delve into Viatris Inc's dividend performance and assess its sustainability.

  • GuruFocus.com

    Insider Sell: President of Greater China Xiangyang Ni Sells 21,532 Shares of Viatris Inc (VTRS)

    Xiangyang Ni, President of Greater China at Viatris Inc (NASDAQ:VTRS), executed a sale of 21,532 shares in the company on March 4, 2024, according to a recent SEC filing.